Company
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| 300mg of TQH2722 injection | Phase 2 | Sinusitis |
Latest
No recent events.
Follow Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.